Xpresspa Group Inc (XSPA)
$1.65
0.07 (4.07%)
XSPA Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
43.95M
PE Ratio
-1.21
EPS
-1.36
Volume (Avg. Vol.)
3.72M
Day's Range
1.63 - 1.74
52-Week Range
0.05 - 5.74
Dividend & Yield
N/A (N/A)
XSPA Stock Predictions, Articles, and Xpresspa Group Inc News
XpresSpa Stock Presents Too Many Concerns to Be a Buy
XSPA is down almost 80% from its June highs for a reason. Investors should continue to avoid this name over future concerns for its business.
To Succeed, XpresSpa Needs a Lot to Go Its Way
After XpresSpa went from spa operator to coronavirus testing center provider, XpresSpa stock is quite risky at this point.
XpresSpa Is Still a Covid-19 Testing Play — But Also Much More
For most of 2020, XpresSpa stock was primarily a Covid-19 testing investment. But recent changes suggest more variety in this company -- and could signal a positive impact on shares.
Despite Covid-19 Surge, Sit Things Out With XpresSpa Stock
With novel coronavirus cases on the rise again, can XpresSpa stock make a comeback? It's debatable, so sit out on this pandemic play.
XpresSpa News: Why XSPA Stock Jumped 3% Today
XpresSpa (XSPA) is in the news Wednesday after a new XpresCheck testing location opening in Boston sent XSPA soaring higher.
A Risky Opportunity Gap Is Available for XpresSpa
Though XpresSpa stock makes fundamental sense, its price action has left much to be desired. Still, the bulls have a longshot opportunity.
XpresSpa News: Why XSPA Stock Is Surging 9% Today
XpresSpa (XSPA) is in the news Tuesday after announcing a business update concerning the novel coronavirus that boosted XSPA stock.
With Early Deadline Misses, Things Are Looking Desperate for XpresSpa Stock
XpresSpa had a clever idea to cope with the economys' collapse, but investors in XSPA stock are waiting for action to justify their bets.
The Key Question Surrounding XpresSpa Group Right Now
XSPA stock soared as the company pivoted to in-airport coronavirus testing. But even if the pivot works, it's unclear what comes next.
Now at a Nice Price, XpresSpa Stock Is Much More Intriguing
If you had doubts about XSPA stock when it was more expensive, that's understandable. Today, though, the shares trade at a discount price.
The Proposition for XpressSpa Stock Looks Worse and Worse by the Day
XpresSpa has refused to release any information about the financial performance of its testing business. That's a very bad sign for XSPA stock.
Identity Crisis Is Hurting XSPA Stock
XPresSpa is having an identity crisis that is impacting its stock price. Investors should avoid this penny stock until the company figures out a sustainable long-term business plan and decides if it will run airport spas or disease testing and vaccination centers going forward. Until then, buying shares of XSPA is too risky and speculative.
XpresSpa Still Presents More Questions Than Answers
XSPA stock is having a terrific year. Bullish investors believe it can turn into a viable resource for Covid-19 testing. That's a questionable assumption.
XpresSpa Group Earnings: XSPA Stock Grows 6% on Q2 Results
XpresSpa Group (XSPA) earnings for the health and wellness company's second quarter of 2020 have XSPA stock soaring higher after-hours Wednesday.
It’s Now Time to Flip Bullish on XpresSpa
It popped and then dropped, but that won't necessarily be the endgame for contentious yet promising XSPA stock.
Why XpresSpa Is Much More than the Bears Think
XSPA stock isn't a pump-and-dump penny stock scheme; this is an innovative company executing strongly against a huge long-term opportunity.
Is ExpresSpa Group a Buy? The Math Says Yes!
With so many variables impacting XSPA stock, it’s difficult to know where the airport health and wellness center will end up. To get some clarity, investors should look at the math.
XpresSpa Shares Are Facing More Problems
With a vaccine potentially two or three months away, XpressSpa appears to be moving at a snail's pace, increasing the risk posed by XSPA stock.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
